Paper Details

  1. Home
  2. Paper Details

Innovative agents in multiple myeloma.

Author: FaimanBeth, RichardsTiffany

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This article discusses the evolution of treatment for multiple myeloma (MM) and the role of newer agents, such as immunomodulatory drugs and proteasome inhibitors. These agents have dramatically improved survival rates but come with side effects. The article emphasizes the importance of understanding genetic events to personalize treatment and minimize side effects. Nurses and advanced practitioners play a critical role in the treatment team and should be aware of the changing drug landscape and clinical trials for newer MM therapies.
Paper Details　
Original Abstract of the Article :
Multiple myeloma (MM) remains an incurable cancer of the bone marrow plasma cells. However, the overall survival of patients with MM has increased dramatically within the past decade. This is due, in part, to newer agents such as immunomodulatory drugs (lenalidomide, thalidomide, and pomalidomide) a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114494/

データ提供：米国国立医学図書館（NLM）

Fighting Multiple Myeloma: A New Oasis of Hope in Cancer Treatment

Multiple myeloma (MM) is a complex and challenging cancer of the bone marrow, but recent advances in treatment have significantly improved patient outcomes. This review examines the latest developments in MM therapy, highlighting the role of innovative agents such as immunomodulatory drugs and proteasome inhibitors. The authors discuss the importance of personalized treatment approaches, tailored to the specific genetic characteristics of each patient. This review offers a comprehensive overview of the evolving landscape of MM treatment, highlighting the progress made in recent years and the exciting prospects for future research.

Finding New Oases in the Desert of Cancer Research

This review illustrates the remarkable progress made in cancer research, particularly in the treatment of multiple myeloma. It's like discovering new oases in the vast desert of cancer research, offering hope and improved survival for patients. The findings highlight the importance of ongoing research and development to create new therapies that are more effective, targeted, and less toxic.

Navigating the Desert of Cancer: Personalized Treatment Plans

This review emphasizes the importance of personalized medicine in cancer treatment, tailoring therapies to the unique genetic profile of each patient. It's like having a specialized map and compass to navigate the complex terrain of cancer, ensuring that treatment strategies are optimized for individual needs. The findings encourage a shift towards precision medicine, where treatment plans are designed to target the specific characteristics of each patient's cancer.

Dr. Camel's Conclusion

This review highlights the exciting progress made in multiple myeloma treatment, with innovative agents and personalized approaches offering new hope for patients. It's like finding a series of oases in the desert of cancer research, offering sustenance, protection, and the promise of a healthier future.

Date :
  1. Date Completed 2014-08-04
  2. Date Revised 2023-11-10
Further Info :

Pubmed ID

25089218

DOI: Digital Object Identifier

PMC4114494

Related Literature

Article Analysis
・Side Effects of pomalidomide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.